EUR 2.36
(-0.84%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 299.76 Thousand EUR | -4.84% |
2022 | 315.02 Thousand EUR | -19.5% |
2021 | 391.31 Thousand EUR | -33.87% |
2020 | 591.72 Thousand EUR | -24.93% |
2019 | 788.25 Thousand EUR | 7.76% |
2018 | 731.48 Thousand EUR | 58.14% |
2017 | 462.54 Thousand EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 299.76 Thousand EUR | 0.0% |
2023 Q4 | 299.76 Thousand EUR | 0.0% |
2023 Q2 | 386.08 Thousand EUR | 0.0% |
2023 FY | 299.76 Thousand EUR | -4.84% |
2022 Q2 | 391.31 Thousand EUR | 0.0% |
2022 Q4 | 315.02 Thousand EUR | 0.0% |
2022 FY | 315.02 Thousand EUR | -19.5% |
2021 Q4 | 391.31 Thousand EUR | 0.0% |
2021 FY | 391.31 Thousand EUR | -33.87% |
2021 Q2 | 591.72 Thousand EUR | 0.0% |
2020 Q2 | 775.95 Thousand EUR | 0.0% |
2020 Q4 | 591.72 Thousand EUR | 0.0% |
2020 FY | 591.72 Thousand EUR | -24.93% |
2019 Q2 | 788.25 Thousand EUR | 0.0% |
2019 Q4 | 788.25 Thousand EUR | 0.0% |
2019 FY | 788.25 Thousand EUR | 7.76% |
2019 Q3 | 788.25 Thousand EUR | 0.0% |
2018 Q4 | 731.48 Thousand EUR | 0.0% |
2018 FY | 731.48 Thousand EUR | 58.14% |
2017 FY | 462.54 Thousand EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Philogen S.p.A. | 1.92 Million EUR | 84.436% |
Ulisse Biomed S.p.A. | 414.99 Thousand EUR | 27.766% |